By interacting with the PI3K/AKT/mTOR pathway, salvianolic acid B, rutin, and chlorogenic acid have been shown to provide therapeutic benefits in managing diabetes, breast cancer, and esophageal cancer [42–44]. Here, AKT1 is linked to esophageal cancer.